Funds holding IO BIOTECH INC
ISIN US4497781090 · United States
- Fund holders
- 0
No tracked fund declares this company in its latest report.
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | -1 | 33,307 | -69.2 % |
| 2026Q1 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q4 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q3 | 2 | 0 | 108,307 | 0.0 % |
| 2025Q2 | 2 | 0 | 108,307 | -47.8 % |
| 2025Q1 | 2 | -1 | 207,307 | -62.1 % |
| 2024Q4 | 3 | 0 | 546,907 | +15.9 % |
| 2024Q3 | 3 | +1 | 471,907 | +216.6 % |
| 2024Q2 | 2 | 0 | 149,040 | -5.6 % |
| 2024Q1 | 2 | 0 | 157,930 | +9.0 % |
| 2023Q4 | 2 | 144,930 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Ikarian Capital, LLC | 1,386,565 | 81.4K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 451,852 | 26.5K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 348,352 | 20 $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 301,291 | 18.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 265,792 | 15.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 206,215 | 12.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 194,158 | 11.4K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 72,495 | 4.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 57,974 | 3.4K $ | as of Mar 31, 2026 |
| Beacon Pointe Advisors, LLC | 42,600 | 2.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 33,307 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 30,977 | 1.8K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding IO BIOTECH INC". https://titelia.com/en/stocks/io-biotech-inc-US4497781090